4//SEC Filing
MISSLING CHRISTOPHER U 4
Accession 0001731122-23-001246
CIK 0001314052other
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 8:00 PM ET
Size
12.4 KB
Accession
0001731122-23-001246
Insider Transaction Report
Form 4
MISSLING CHRISTOPHER U
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2023-06-28−268,000→ 232,000 totalExercise: $1.60From: 2013-07-05Exp: 2023-07-05→ Common Stock (268,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2023-06-29−232,000→ 0 totalExercise: $1.60From: 2013-07-05Exp: 2023-07-05→ Common Stock (232,000 underlying) - Exercise/Conversion
Common Stock
2023-06-28$1.60/sh+268,000$428,800→ 1,286,210 total - Sale
Common Stock
2023-06-28$7.98/sh−268,000$2,139,310→ 1,018,210 total - Exercise/Conversion
Common Stock
2023-06-29$1.60/sh+232,000$371,200→ 1,250,210 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.95 to $8.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
Documents
Issuer
ANAVEX LIFE SCIENCES CORP.
CIK 0001314052
Entity typeother
Related Parties
1- filerCIK 0001196573
Filing Metadata
- Form type
- 4
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 8:00 PM ET
- Size
- 12.4 KB